Scrip Asks…What Does 2023 Hold For Biopharma? Part 8: Therapeutic Area Advances
CNS Rises In Prominence Following Alzheimer’s Progress
Neuroscience and oncology fuel high hopes for therapeutic R&D progress among 90-plus surveyed biopharma industry leaders.
